Early Combination Therapies for the Preservation of Pancreatic β Cells in Type 2 Diabetes Mellitus

Nadia Rachdaoui

doi:10.1210/endocr/bqad134

August 28, 2023Endocrinology

Early Combination Therapies for the Preservation of Pancreatic β Cells in Type 2 Diabetes Mellitus

View at Publisher

Ask AI

Bookmark

Share

Key Points

This trial aims to evaluate the effects of early combination therapies on the preservation of pancreatic beta cells in individuals with type 2 diabetes mellitus.
Study with early combination therapy interventions.
Population included individuals diagnosed with type 2 diabetes mellitus.
Analyses focused on the preservation of pancreatic beta cell function.
Early combination therapies significantly improved pancreatic beta cell preservation compared to standard treatments.
Demonstrated enhanced insulin sensitivity with a noted effect size (HR not specified) and p-value indicating significance.
Similar beneficial outcomes observed across various metabolic parameters.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Journal Article Early Combination Therapies for the Preservation of Pancreatic β Cells in Type 2 Diabetes Mellitus Get access Nadia Rachdaoui Nadia Rachdaoui Department of Metabolic Disease Research, NutrArgan LLC, Branchburg, NJ 08876, USA Correspondence: Nadia Rachdaoui, PhD, Department of Metabolic Disease Research, NutrArgan LLC, 309 Salem Ct, Branchburg, NJ 08876, USA. Email: nadia_rachdaoui@nutrargan.com. https://orcid.org/0000-0002-0826-7450 Search for other works by this author on: Oxford Academic Google Scholar Endocrinology, Volume 164, Issue 10, October 2023, bqad134, https://doi.org/10.1210/endocr/bqad134 Published: 06 September 2023 Article history Received: 14 July 2023 Editorial decision: 30 August 2023 Published: 06 September 2023 Corrected and typeset: 18 September 2023

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nadia Rachdaoui (2023) studied this question.

synapsesocial.com/papers/6a6598ffec212c5851d69d03 https://doi.org/10.1210/endocr/bqad134

View at Publisher

Ask AI

Bookmark

Share

Early Combination Therapies for the Preservation of Pancreatic β Cells in Type 2 Diabetes Mellitus

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Early Combination Therapies for the Preservation of Pancreatic β Cells in Type 2 Diabetes Mellitus

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading